Followers | 7 |
Posts | 604 |
Boards Moderated | 0 |
Alias Born | 03/08/2017 |
Thursday, March 30, 2017 2:42:53 PM
ConocoPhillips (COP +6.4%) is the top gainer on the S&P 500 in early trading amid widespread praise for the sale of its 50% interest in the FCCL partnership with Cenovus Energy (CVE -10.6%), as it allows for debt reduction and share buybacks.
Cowen analyst Charles Robertson says some investors were skeptical of COP's plan announced in November to sell $3B-$5B in assets and buy back $3B worth of stock, but the "unexpected big deal" with CVE accomplished the plan in less than a year.
UBS upgrades shares to Buy from Neutral with a $55 price target, up from $51, saying COP is divesting a “low growth, low margin asset that will enable it to immediately reduce its debt load by ~$7B," and the deal improves COP’s production mix with lower margin bitumen dropping to 5% from 15% as higher margin oil increases to 40% from 35%.
Evercore ISI says the deal creates “significant value," and appears accretive to return on equity, earnings and cash margins; analyst Doug Terreson says COP management is leading Big Oil and the E&P industry on positive, shareholder oriented change.
Recent COP News
- ConocoPhillips announces first-quarter 2024 results, quarterly dividend and VROC • Business Wire • 05/02/2024 11:00:00 AM
- ConocoPhillips to hold first-quarter earnings conference call on Thursday, May 2 • Business Wire • 03/21/2024 06:30:00 PM
- AM Best Affirms Credit Ratings of Sooner Insurance Company • Business Wire • 03/07/2024 03:51:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 11:25:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 04:31:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 04:24:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:02:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:53:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:47:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 09:12:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 09:25:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 07:01:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:15:32 PM
- ConocoPhillips announces Dominic Macklon to retire after 33 years with the company • Business Wire • 02/15/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 11:19:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 11:15:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 11:10:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 11:07:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 11:00:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:57:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:54:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:50:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:47:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:44:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 11:07:15 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM